Targeting a Specific Glycosylated Epitope of CD43 with a New Humanized Monoclonal Antibody for the Treatment of Pediatric and Adult T-Cell Acute Lymphoblastic Leukemia (T-ALL)
Cirino Botta(Ospedale Annunziata di Cosenza), Pierfrancesco Tassone(Magna Graecia University), Maria Teresa Di Martino(Centro Clinico Nemo), Katia Grillone(Magna Graecia University), Andrea Biondi(University of Milano-Bicocca), Franca Maria Tuccillo(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Maria Cucè(Magna Graecia University), Marco Rossi(Magna Graecia University), Caterina Riillo(Magna Graecia University), Maria Anna Siciliano(Magna Graecia University), Chiara Buracchi(Fondazione Humanitas per la Ricerca), Alessandro Gulino(University of Palermo), Giovanni Martinelli(University of Bologna), Nicoletta Staropoli(Magna Graecia University), Giuseppe Gaipa(University of Milano-Bicocca), Claudio Tripodo(University of Palermo), Maria Eugenia Gallo Cantafio(Magna Graecia University), Pierosandro Tagliaferri(Magna Graecia University), Andrea Ghelli Luserna di Rorà(Fondazione Pisa)
Cited by 1
Related Papers
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
|The Lancet Oncology|2009|1k
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
|New England Journal of Medicine|2005|644